Literature DB >> 17048303

Association of Graves' disease and Graves' ophthalmopathy with the polymorphisms in promoter and exon 1 of cytotoxic T lymphocyte associated antigen-4 gene.

Qin Zhang1, Yun-mei Yang, Xue-ying Lv.   

Abstract

OBJECTIVE: To investigate the association of Graves' disease and Graves' ophthalmopathy with the C/T transition polymorphism at position -318 of promoter and the A/G transition polymorphism at position 49 of exon 1 within cytotoxic T lymphocyte associated antigen-4 (CTLA-4) gene.
METHODS: Thirty-three patients with ophthalmopathy of Graves' disease, fifty-six Graves' patients without ophthalmopathy and sixty normal subjects as control were involved in the present case-control study. The polymorphisms were evaluated by polymerase chain reaction fragment length polymorphism (PCR-RFLP). Comparisons were made of gene frequencies and allele frequencies between the groups.
RESULTS: The gene frequencies of CT and allele frequencies of T were much higher in Graves' patients with ophthalmopathy than that in the group without ophthalmopathy (P=0.020, P=0.019). The gene frequencies of GG and allele frequencies of G in patients with Graves' disease were significantly increased as compared with control group (P=0.008, P=0.007). The data suggest that smokers with Graves' disease seemed to be more predisposed to ophthalmopathy than non-smokers (P=0.018).
CONCLUSION: Our results suggest that an allele of T at position -318 of promoter is associated with genetic susceptibility to Graves' ophthalmopathy while an allele of G at position 49 of exon 1 is associated with genetic susceptibility to Graves' disease instead. Smoking is believed to be a major risk factor for ophthalmopathy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17048303      PMCID: PMC1635815          DOI: 10.1631/jzus.2006.B0887

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  14 in total

1.  CTLA-4 gene polymorphisms in Tunisian patients with Graves' disease.

Authors:  H Hadj Kacem; M Bellassoued; N Bougacha-Elleuch; M Abid; H Ayadi
Journal:  Clin Immunol       Date:  2001-12       Impact factor: 3.969

2.  No evidence for allelic association of a human CTLA-4 promoter polymorphism with autoimmune thyroid disease in either population-based case-control or family-based studies.

Authors:  J M Heward; A Allahabadia; J Carr-Smith; J Daykin; C S Cockram; C Gordon; A H Barnett; J A Franklyn; S C Gough
Journal:  Clin Endocrinol (Oxf)       Date:  1998-09       Impact factor: 3.478

3.  A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation.

Authors:  G Shaw; R Kamen
Journal:  Cell       Date:  1986-08-29       Impact factor: 41.582

4.  Is endocrine ophthalmopathy related to smoking?

Authors:  E Hägg; K Asplund
Journal:  Br Med J (Clin Res Ed)       Date:  1987-09-12

5.  CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus.

Authors:  H Donner; H Rau; P G Walfish; J Braun; T Siegmund; R Finke; J Herwig; K H Usadel; K Badenhoop
Journal:  J Clin Endocrinol Metab       Date:  1997-01       Impact factor: 5.958

6.  Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism confers susceptibility to thyroid associated orbitopathy.

Authors:  B Vaidya; H Imrie; P Perros; J Dickinson; M I McCarthy; P Kendall-Taylor; S H Pearce
Journal:  Lancet       Date:  1999-08-28       Impact factor: 79.321

7.  Superoxide radical production stimulates retroocular fibroblast proliferation in Graves' ophthalmopathy.

Authors:  H B Burch; S Lahiri; R S Bahn; S Barnes
Journal:  Exp Eye Res       Date:  1997-08       Impact factor: 3.467

8.  Anti-heat shock protein (hsp)72 antibodies are present in patients with Graves' disease (GD) and in smoking control subjects.

Authors:  M F Prummel; Y Van Pareren; O Bakker; W M Wiersinga
Journal:  Clin Exp Immunol       Date:  1997-11       Impact factor: 4.330

9.  Cigarette smoking and treatment outcomes in Graves ophthalmopathy.

Authors:  L Bartalena; C Marcocci; M L Tanda; L Manetti; E Dell'Unto; M P Bartolomei; M Nardi; E Martino; A Pinchera
Journal:  Ann Intern Med       Date:  1998-10-15       Impact factor: 25.391

10.  CTLA-4 promoter variants in patients with Graves' disease and Hashimoto's thyroiditis.

Authors:  J Braun; H Donner; T Siegmund; P G Walfish; K H Usadel; K Badenhoop
Journal:  Tissue Antigens       Date:  1998-05
View more
  11 in total

Review 1.  The risk factors for Graves' ophthalmopathy.

Authors:  Jiamin Cao; Yuhe Su; Zhuokun Chen; Chen Ma; Wei Xiong
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-11-17       Impact factor: 3.117

2.  Association of the CTLA4 gene CT60/rs3087243 single-nucleotide polymorphisms with Graves' disease.

Authors:  Weizhen Fang; Zhixian Zhang; Jin Zhang; Zhenhua Cai; Hua Zeng; Mei Chen; Junqi Huang
Journal:  Biomed Rep       Date:  2015-07-27

Review 3.  The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: back to the future.

Authors:  Eric M Jacobson; Yaron Tomer
Journal:  J Autoimmun       Date:  2007-03-21       Impact factor: 7.094

4.  Graves' ophthalmopathy: a review of immunogenetics.

Authors:  Omid Khalilzadeh; Sina Noshad; Armin Rashidi; Aliakbar Amirzargar
Journal:  Curr Genomics       Date:  2011-12       Impact factor: 2.236

Review 5.  Cytotoxic T lymphocyte-associated antigen 4 gene polymorphisms and autoimmune thyroid diseases: an updated systematic review and cumulative meta-analysis.

Authors:  Hai-Feng Hou; Xu Jin; Tao Sun; Cheng Li; Bao-Fa Jiang; Qun-Wei Li
Journal:  Int J Endocrinol       Date:  2015-03-24       Impact factor: 3.257

6.  Associations of CTLA4 Gene Polymorphisms with Graves' Ophthalmopathy: A Meta-Analysis.

Authors:  Pengfei Du; Xiaojie Ma; Changjiang Wang
Journal:  Int J Genomics       Date:  2014-07-09       Impact factor: 2.326

7.  Distribution of Cytotoxic T Lymphocyte-Associated Antigen-4 Promoter Polymorphisms in Taiwanese Patients with Type 2 Diabetes Mellitus.

Authors:  Yung-Luen Shih; Hsu-Feng Lu; Chiao-Wan Hsiao; Kuo-Ting Ho; Pei-Chi Chen; Chien-Ning Huang; Yuanmay Chang; Shang-Jyh Kao; Ming-Yuh Shiau; Yih-Hsin Chang
Journal:  Int J Med Sci       Date:  2018-02-12       Impact factor: 3.738

8.  Association between the CTLA-4 +49A/G polymorphism and Graves' disease: A meta-analysis.

Authors:  Xiaoyu Si; Xiufeng Zhang; Wenru Tang; Ying Luo
Journal:  Exp Ther Med       Date:  2012-06-20       Impact factor: 2.447

9.  The associations between the polymorphisms in the CTLA-4 gene and the risk of Graves' disease in the Chinese population.

Authors:  Liang Du; Jiqiao Yang; Jichong Huang; Yaxian Ma; Haichuan Wang; Tianyuan Xiong; Zhangpeng Xiang; Yonggang Zhang; Jin Huang
Journal:  BMC Med Genet       Date:  2013-04-19       Impact factor: 2.103

10.  Association of Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4) Gene Polymorphisms with Autoimmune Thyroid Disease in Children and Adults: Case-Control Study.

Authors:  Wei-Hsin Ting; Ming-Nan Chien; Fu-Sung Lo; Chao-Hung Wang; Chi-Yu Huang; Chiung-Ling Lin; Wen-Shan Lin; Tzu-Yang Chang; Horng-Woei Yang; Wei-Fang Chen; Ya-Ping Lien; Bi-Wen Cheng; Chao-Hsu Lin; Chia-Ching Chen; Yi-Lei Wu; Chen-Mei Hung; Hsin-Jung Li; Chon-In Chan; Yann-Jinn Lee
Journal:  PLoS One       Date:  2016-04-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.